Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies

We describe a case of fulminant onset, rapidly progressive-interstitial lung disease (RP-ILD) with anti-ARS antibodies (anti-PL-7). The patient was successfully treated with nintedanib in addition to intensive immunosuppressive therapies, including intravenous cyclophosphamide. Nintedanib has just b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagihara, Toyoshi, Suzuki, Kunihiro, Egashira, Ayaka, Ogo, Naruhiko, Asoh, Tatsuma, Nara, Tsukasa, Takatsuki, Kensaku, Yoshizawa, Seiji, Chong, Sy Giin, Hamada, Naoki, Maeyama, Takashige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606860/
https://www.ncbi.nlm.nih.gov/pubmed/33163354
http://dx.doi.org/10.1016/j.rmcr.2020.101272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606860/
https://www.ncbi.nlm.nih.gov/pubmed/33163354
http://dx.doi.org/10.1016/j.rmcr.2020.101272

Ejemplares similares